http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-093857-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_130efb8ab1446af2ced47bb5f1b4b789 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-093857-A1 |
| titleOfInvention | ULTIRISTAL ACETATE CRYSTALLINE POLYMORPHIC FORM |
| abstract | A crystalline polymorphic form of ulipristal acetate useful as an agent for preventing and / or treating uterine leiomyoma and as a contraceptive and a process for producing the crystalline polymorphic form is provided. The crystalline polymorphic form of ulipristal acetate is obtained by dissolving an ulipristal acetate crystal solvated with isopropanol in a mixed solvent containing ethanol and water and crystallizing an ulipristal acetate from the solution without adding a seed crystal to the solution. Claim 1: A crystalline polymorphic form C of ulipristal acetate having an X-ray powder diffraction pattern comprising diffraction peaks at the following 2q diffraction angles: 9.0 ± 0.2 °, 9.3 ± 0, 2nd, 10.8 ± 0.2º, 11.5 ± 0.2º, 12.2 ± 0.2º, 13.1 ± 0.2º, 14.3 ± 0.2º, 15.6 ± 0.2º, 15.7 ± 0.2º, 15.9 ± 0.2º, 16.6 ± 0.2º, 17.6 ± 0.2º, 17.9 ± 0.2º, 18.9 ± 0.2º, 19, 3 ± 0.2º, 23.8 ± 0.2º. |
| priorityDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.